메뉴 건너뛰기
PLoS Medicine
Volumn 13, Issue 1, 2016, Pages
Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry
Author keywords

[No Author keywords available]
Indexed keywords

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DRUG INDUSTRY; EMERGENCY HEALTH SERVICE; HEALTH CARE; HUMAN; INFECTION; INFORMATION DISSEMINATION; PATIENT CODING; PUBLICATION; SCIENTIFIC LITERATURE; EMERGENCY; GLOBAL HEALTH; PROCEDURES; PUBLIC HEALTH; TRENDS; WORLD HEALTH ORGANIZATION;
EID: 84961348297     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001936     Document Type: Article
Times cited : (20)
References (7)
  • 1
    • 84961291709 scopus 로고    scopus 로고
    • Developing global norms for sharing data and results during public health emergencies
    • Modjarrad K, Moorthy VS, Millet P, Gsell P-S, Roth C, Kieny M-P, Developing global norms for sharing data and results during public health emergencies. PLoS Med 2015; 13(1);e1001935. doi: 10.1371/journal.pmed.1001935
    • (2015) PLoS Med , vol.13 , Issue.1 , pp. e1001935
    • Modjarrad, K.1    Moorthy, V.S.2    Millet, P.3    Gsell, P.-S.4    Roth, C.5    Kieny, M.-P.6
  • 2
    • 84961356092 scopus 로고    scopus 로고
    • The Royal Society. Science as an open enterprise. https://royalsociety.org/~/media/policy/projects/sape/2012-06-20-saoe.pdf
  • 3
    • 84961314724 scopus 로고    scopus 로고
    • Institute of Medicine. Sharing clinical trial data: maximizing benefit, minimizing risk. http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx
  • 4
    • 84880893300 scopus 로고    scopus 로고
    • Access to patient-level data from GlaxoSmithKline clinical trials
    • Nisen P, Rockhold F, Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med 2013; 369: 475–478. doi: 10.1056/NEJMsr1302541 23902490
    • (2013) N Engl J Med , vol.369 , pp. 475-478
    • Nisen, P.1    Rockhold, F.2
  • 5
    • 77952704258 scopus 로고    scopus 로고
    • Thousands of chemical starting points for antimalarial lead identification
    • Gamo F-J, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera J-L, et al (2010). Thousands of chemical starting points for antimalarial lead identification. Nature 2010; 465 (7296): 305–310. doi: 10.1038/nature09107 20485427
    • (2010) Nature , vol.465 , Issue.7296 , pp. 305-310
    • Gamo, F.-J.1    Sanz, L.M.2    Vidal, J.3    de Cozar, C.4    Alvarez, E.5    Lavandera, J.-L.6
  • 6
    • 84961346087 scopus 로고    scopus 로고
    • Breaking the R&D deadlock: could Open Labs be the key to cracking the world’s toughest health problems?
    • Borysiewicz L, Strange M, Atun R, Breaking the R&D deadlock: could Open Labs be the key to cracking the world’s toughest health problems? The Lancet Global Health Blog [Internet] 14th November 2014. http://globalhealth.thelancet.com/2014/11/14/breaking-rd-deadlock-could-open-labs-be-key-cracking-worlds-toughest-health-problems
    • (2014) The Lancet Global Health Blog
    • Borysiewicz, L.1    Strange, M.2    Atun, R.3
  • 7
    • 84884668276 scopus 로고    scopus 로고
    • Secure use of individual patient data from clinical trials
    • Vallance P, Chalmers I, Secure use of individual patient data from clinical trials. The Lancet 2013; 382: 1073–1074.
    • (2013) The Lancet , vol.382 , pp. 1073-1074
    • Vallance, P.1    Chalmers, I.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.